PIPELINE
 | Materializing the potentials of Cell & Gene Therapy We believe our iPSCs platform has the potential to reshape cellular medicine. HELP Therapeutics harnesses the potentials of Stem Cells and Gene Engineering to develop the next generation medicine. Our ultimate goal is to provide Cure for currently intractable diseases such as Heart Failure and Parkinson's dis |
Project 1: Cell Therapy for Heart Failure
Why Heart Failure?
Heart failure is a life-threatening disease condition endangering over 30 million individuals worldwide. Heart transplantation is the only effective treatment available, but is severely hindered by the lack of donor. Currently, less than 1% of Heart Failure patients may receive transplantation.
The Solution
Patented technologies of HELP Therapeutics allowed the derivation of highly pure cardiomyocytes from induced-pluripotent stem cells (iPSCs). Transplantation of these cardiomyocytes promoted heart regeneration and functional recovery in non-human primates.
HELP Therapeutics initiated first-in-man clinical study involving the transplantation of iPSC-derived cardiomyocytes (iCMs) into heart failure patients. Cell therapy product based on iCMs is expected to enter the market in 3 years.
